Geode Capital Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.77M | Buy |
|
|||||
|
2025
Q1 | $5.1M | Buy |
|
|||||
|
2024
Q4 | $6.18M | Buy |
|
|||||
|
2024
Q3 | $7.16M | Buy |
|
|||||
|
2024
Q2 | $6.45M | Buy |
|
|||||
|
2024
Q1 | $2.93M | Buy |
|
|||||
|
2023
Q4 | $1.74M | Buy |
|
|||||
|
2023
Q3 | $1.46M | Buy |
|
|||||
|
2023
Q2 | $237K | Sell |
|
|||||
|
2023
Q1 | $300K | Buy |
|
|||||
|
2022
Q4 | $749K | Buy |
|
|||||
|
2022
Q3 | $464K | Buy |
|
|||||
|
2022
Q2 | $886K | Sell |
|
|||||
|
2022
Q1 | $2.67M | Buy |
|
|||||
|
2021
Q4 | $4.55M | Buy |
|
|||||
|
2021
Q3 | $6.76M | Buy |
|
|||||
|
2021
Q2 | $5.58M | Buy |
|
|||||
|
2021
Q1 | $3.09M | Sell |
|
|||||
|
2020
Q4 | $4.35M | Buy |
|